Can Functional Motor Capacity Influence Mortality in Advanced Chronic Kidney Disease Patients?
Nutrients · 2024
DOI: 10.3390/nu16162689 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nutrients, 2024. Verfasst von Ángel Nogueira-Pérez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Avericum, 35220 Las Palmas, Spain. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Nutritional Status, Body Composition. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Alterations in the body’s nutritional status or composition may be observed as the kidney disease advances, which could influence the kidney’s functional capacity and, consequently, could increase the risk of mortality. The aim of the study is to determine the influence of functional capacity on mortality assessed by different functional tests in patients with advanced chronic kidney disease (ACKD). A prospective observational study was designed, which included 225 patients followed for 8 years in a CKD clinic. The study assessed functional capacity by using a range of tests, which included the Short Physical Performance Battery, the 6 minutes walking gait test, the timed up and go, and the four versions of the sit-to-stand test. Additionally, body composition and nutritional conditions were considered, taking into consideration various biochemical indicators such as albumin, prealbumin, c-reactive protein (CRP), lymphocytes, and transferrin, muscle strength, comorbidity, and frailty. The relationship between functionality and all-cause mortality was investigated using a Cox proportional hazard model. A total of fifty patients died during the duration of the study. Patients who performed worse on the function and muscle strength tests showed a worse body composition and nutritional status, and exhibited a reduced life expectancy. Inflammation (CRP) was associated with an increased risk of mortality (model 1: hazard ratio (HR) = 1.246; 95% confidence interval (95% CI = 1.014–1.531; model 2: HR = 1.333; 95% CI = 1.104–1.610). Good functional capacity as determined by the SPPB test decreased the risk of mortality (model 1: HR = 0.764; 95% CI = 0.683–0.855; model 2 HR = 0.778; 95% CI = 0.695–0.872). Cut-off points of maximum sensitivity and specificity for mortality were obtained with different tests. The study demonstrated that functional capacity influences mortality in patients with ACKD, being higher in those patients with impaired functionality regardless of the test used, although the SPPB allows a larger number of patients to be assessed. Therefore, it is essential to incorporate the assessment of functionality into the comprehensive care of patients with CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Avericum, 35220 Las Palmas, Spain.
- Department of Nephrology, Hospital Universitario de la Princesa, 28006 Madrid, Spain.
- Fundación Investigaciones Bioimédicas, 28290 Las Rozas de Madrid, Spain.
ORCID-Profile: Paloma Ruiz-López-Alvarado, Guillermina Barril-Cuadrado
Zitieren
APA
Nogueira-Pérez, Á., Ruiz-López-Alvarado, P., & Barril-Cuadrado, G. (2024). Can Functional Motor Capacity Influence Mortality in Advanced Chronic Kidney Disease Patients?. Nutrients. https://doi.org/10.3390/nu16162689
Vancouver
Nogueira-Pérez Á, Ruiz-López-Alvarado P, Barril-Cuadrado G. Can Functional Motor Capacity Influence Mortality in Advanced Chronic Kidney Disease Patients?. Nutrients. 2024. doi:10.3390/nu16162689
BibTeX
@article{NogueiraPrez2024,
author = {Nogueira-Pérez, Ángel and Ruiz-López-Alvarado, Paloma and Barril-Cuadrado, Guillermina},
title = {Can Functional Motor Capacity Influence Mortality in Advanced Chronic Kidney Disease Patients?},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16162689}
}
EUVIMED